- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma ; volume:13 ; number:1 ; day:1 ; month:12 ; year:2013 ; pages:1-4 ; date:12.2013
BMC cancer ; 13, Heft 1 (1.12.2013), 1-4, 12.2013
- Creator
-
Wolf, Sanne EJ
- Contributor
-
Meenken, Christina
Moll, Annette C.
Haanen, John B.
van der Heijden, Michiel S.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-13-561
- URN
-
urn:nbn:de:1111-2016030410946
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wolf, Sanne EJ
- Meenken, Christina
- Moll, Annette C.
- Haanen, John B.
- van der Heijden, Michiel S.
- SpringerLink (Online service)
Other Objects (12)
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma
Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
METASTATIC MALIGNANT MELANOMA OF SKIN
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma
Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
METASTATIC MALIGNANT MELANOMA OF SKIN
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma
Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
METASTATIC MALIGNANT MELANOMA OF SKIN
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report